Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)
Clinical trial NCT06605105 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06605105
- Sponsor
- Cybin IRL Limited
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-18
- Primary completion
- 2028-03-15
- Enrollment
- 468
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.